Thursday September 17/2008
12:10: The Health Roundup with Jay McQueen.
12:12: Canada has become the first country to approve Xarelto® (rivaroxaban), the first in a new class of anticoagulants, for the prevention of venous thromboembolic events (VTE), or venous blood clots in patients who have undergone elective total hip or total knee replacement surgery. The number of patients undergoing these types of surgeries is on the rise as the population ages.
Guest: Dr. A.G.G. Turpie, Professor of Medicine, McMaster University, and Principal Investigator for the RECORD program.
12:20: A new high-performance athlete testing lab is being set up at McMaster University. What’s involved here? What’s the use of such a facility? Who benefits?
Guest: Guest: Steve Lidstone, Strength and Conditioning Co-ordinator, McMaster Athletics & Recreation.
12:35: Doctors in Prince Edward Island want the provincial government there to ban the sale of caffeine-laden energy drinks to kids!
Guest: Dr. Bill Scantlebury, President, PEI Medical Society.
12:45: Rexall Pharmacy segment.
Guest: Irene Hogan.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment